Various genetic causes of cancer disrupt a type of DNA repair, imposing a telltale pattern of secondary variants in cancer-cell genomes and raising the question of whether patients would benefit from treatment based on whether this “genome scar” is in their cancer cells.
No takes yet. Share an insight, caveat, or question.
Nicholas C. Turner (2017) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: